- Home
- ELAN vs ALLY Comparison
ELAN vs ALLY Comparison
Compare ELAN & ALLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELAN | ALLY |
|---|---|---|
| Founded | 1954 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.3B |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ELAN | ALLY |
|---|---|---|
| Price | $22.16 | $44.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $27.89 | ★ $54.42 |
| AVG Volume (30 Days) | ★ 3.9M | 3.4M |
| Earning Date | 05-06-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | N/A | ★ 31.67 |
| EPS | N/A | ★ 2.37 |
| Revenue | $4,715,000,000.00 | ★ $7,914,000,000.00 |
| Revenue This Year | $8.21 | $24.30 |
| Revenue Next Year | $5.31 | $4.31 |
| P/E Ratio | ★ N/A | $18.77 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $9.32 | $31.46 |
| 52 Week High | $27.72 | $47.27 |
Technical Indicators
Market Signals| Indicator | ELAN | ALLY |
|---|---|---|
| Relative Strength Index (RSI) | 39.98 | 61.14 |
| Support Level | $20.73 | $37.23 |
| Resistance Level | $23.16 | $46.83 |
| Average True Range (ATR) | 0.86 | 1.15 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 14.82 | 56.16 |
Price Performance
Historical ComparisonAbout ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.